Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Scientists Grow Neurons Using Nanostructures
Uncategorized

Scientists Grow Neurons Using Nanostructures

By medwebJan 1, 2004
Share
Facebook Twitter Email

Scientists Grow Neurons Using Nanostructures

Scientists at Northwestern University have designed synthetic molecules that promote neuron growth, a promising development that could lead to the reversal of paralysis due to spinal cord injury.

“We have created new materials that because of their chemical structure interact with cells of the central nervous system in ways that may help prevent the formation of the scar that is often linked to paralysis after spinal cord injury,” said Samuel I. Stupp, PhD, Board of Trustees Professor of Materials Science and Engineering, Chemistry, and Medicine.

Similar to earlier experiments that promoted bone growth, the scientists now have successfully grown nerve cells using an artificial three-dimensional network of nanofibers, an important technique in regenerative medicine. The results were published online by the journal Science.

The gel formed when 1 percent of an aqueous IKVAV-PA solution is mixed with cell media on a glass cover slip (12mm). Under these physiological conditions the IKVAV-PA self-assembles into nanofibers that interact to cause macroscopic gel formation.

“We have shown that our scaffold selectively and rapidly directs cell differentiation, driving neural progenitor cells to become neurons and not astrocytes,” said Dr. Stupp, who led the research team in Evanston. “Astrocytes are a major problem in spinal cord injury because they lead to scarring and act as a barrier to neuron repair.”

The innovative scaffold is made up of nanofibers formed by peptide amphiphile molecules. The scientists’ key breakthrough was designing the peptide amphiphiles so that when they self-assembled into the scaffold a specific sequence of five amino acids known to promote neuron growth was presented in enormous density on the outer surfaces.

“This was all done by design,” said Dr. Stupp, who is also director of the University’s Institute for Bioengineering and Nanoscience in Advanced Medicine. “By including a specific biological signal on the nanostructure we were able to customize the new materials for neurons.”

In collaboration with the lab of John A. Kessler, MD, Benjamin and Virginia T. Boshes Professor of Neurology at the Feinberg School, Dr. Stupp and his team observed that when the peptide amphiphiles were placed in solution and combined with neural progenitor cells (which are present in the central nervous system and able to differentiate into different types of cells) the nanofiber scaffolds formed and led quickly to the selective differentiation of the cells into neurons.

In subsequent experiments, the researchers successfully delivered the peptide amphiphile solution, using a simple injection, to the site of a spinal cord injury in a laboratory rat. Upon contact with the tissue, the solution was transformed into a solid scaffold.

In addition to Drs. Stupp and Kessler, other authors on the Science paper are Gabriel A. Silva and Catherine Czeisler (lead authors), Krista L. Niece, Elia Beniash, PhD, and Daniel Harrington, all from Northwestern University.

The research was supported by the National Science Foundation, the National Institutes of Health, and the U.S. Department of Energy.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.